Surveillance Fragmentation: Global Disease Early Warning Is Handicapped by Fragmented, Under-Resourced, Unequal Infrastructure
Problem Definition
The global disease surveillance system is fundamentally broken. Countries with resources — wealthy OECD nations, China — have robust lab networks, sequencing capacity, and real-time reporting. Most developing nations have almost none.
There is no integrated global surveillance network; instead, there are hundreds of parallel, incompatible systems (national, regional, WHO regional offices, CDC-supported networks, private sector) that don't reliably share data.
When a novel pathogen emerges, detection and characterization depends almost entirely on chance: which country it emerges in, whether that country has lab capacity, whether they choose to report it, and whether delays in reaching international systems allow exponential spread first. COVID-19 demonstrated that luck runs out.
Root Causes
Surveillance infrastructure is publicly funded but under-resourced relative to the threat — governments spend 10x more on pandemic response than prevention
No international funding mechanism for surveillance in low-income countries — they depend on sporadic donor support from WHO and USAID
Laboratory capacity in 80+ low-income countries remains at 1990s levels despite decades of disease outbreaks
Pathogen sequencing is concentrated in wealthy countries — a Ghanaian scientist sequences a novel virus in Ghana, but the sequencing happens in the US
Real-time data sharing is constrained by national sovereignty concerns and IP disputes over pathogens and genetic data